13F HOLDINGS REPORT (Amended)
Sofinnova Investments, Inc.
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001104659-24-089526
Total Value
$1.80B
Positions
74
Other Managers
0
Confidential Omitted
No
Holdings (74)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Natera Inc | NTRA | 1,550,280 | $141.8M | 7.90% |
| 2 | Vera Therapeutics Inc | VERA | 2,793,987 | $120.5M | 6.71% |
| 3 | Ascendis Pharma A/S | ASND | 754,032 | $114.0M | 6.35% |
| 4 | Aerovate Therapeutics Inc | 008064107 | 3,758,686 | $111.1M | 6.19% |
| 5 | Merck & Co Inc | MRK | 651,299 | $85.9M | 4.79% |
| 6 | Spdr Ser Tr | 78464A870 | 850,000 | $80.7M | 4.49% |
| 7 | Novo-Nordisk A S | NONOF | 611,884 | $78.6M | 4.38% |
| 8 | Incyte Corp | INCY | 1,327,178 | $75.6M | 4.21% |
| 9 | Argenx SE | ARGX | 149,300 | $58.8M | 3.27% |
| 10 | Intuitive Surgical Inc | ISRG | 140,880 | $56.2M | 3.13% |
| 11 | Dyne Therapeutics Inc | DYN | 1,936,650 | $55.0M | 3.06% |
| 12 | Inhibrx Inc | INBX | 1,302,645 | $45.5M | 2.54% |
| 13 | Elanco Animal Health Inc | ELAN | 2,555,547 | $41.6M | 2.32% |
| 14 | IDEXX Labs Inc | 45168D104 | 75,224 | $40.6M | 2.26% |
| 15 | AstraZeneca PLC | AZN | 596,713 | $40.4M | 2.25% |
| 16 | Syndax Pharmaceuticals Inc | SNDX | 1,608,540 | $38.3M | 2.13% |
| 17 | Insulet Corp | PODD | 220,203 | $37.7M | 2.10% |
| 18 | Y-mAbs Therapeutics Inc | 984241109 | 2,194,278 | $35.7M | 1.99% |
| 19 | IDEAYA Biosciences Inc | IDYA | 781,596 | $34.3M | 1.91% |
| 20 | Celldex Therapeutics Inc | CLDX | 801,777 | $33.7M | 1.87% |
| 21 | Inozyme Pharma Inc | 45790W108 | 4,280,308 | $32.8M | 1.83% |
| 22 | Align Technology Inc | ALGN | 95,478 | $31.3M | 1.74% |
| 23 | Arrivent Biopharma Inc | AVBP | 1,696,752 | $30.3M | 1.69% |
| 24 | TG Therapeutics Inc | TGTX | 1,984,962 | $30.2M | 1.68% |
| 25 | Sarepta Therapeutics Inc | SRPT | 227,488 | $29.5M | 1.64% |
| 26 | Boston Scientific Corp | BSX | 353,851 | $24.2M | 1.35% |
| 27 | Immatics NV | IMTX | 2,163,646 | $22.7M | 1.27% |
| 28 | Silk Rd Med Inc | 82710M100 | 1,189,024 | $21.8M | 1.21% |
| 29 | Cogent Biosciences Inc | COGT | 2,400,771 | $16.1M | 0.90% |
| 30 | Exact Sciences Corp | 30063P105 | 229,481 | $15.8M | 0.88% |
| 31 | Alnylam Pharmaceuticals Inc | ALNY | 103,036 | $15.4M | 0.86% |
| 32 | Immunome Inc | IMNM | 594,396 | $14.7M | 0.82% |
| 33 | Pharvaris N V | PHVS | 584,672 | $13.5M | 0.75% |
| 34 | Marinus Pharmaceuticals Inc | 56854Q200 | 1,401,053 | $12.7M | 0.71% |
| 35 | Savara Inc | SVRA | 2,347,261 | $11.7M | 0.65% |
| 36 | Shockwave Med Inc | 82489T104 | 35,000 | $11.4M | 0.63% |
| 37 | Kura Oncology Inc | KURA | 501,940 | $10.7M | 0.60% |
| 38 | Roivant Sciences Ltd | ROIV | 1,001,704 | $10.6M | 0.59% |
| 39 | Axonics Inc | 05465P101 | 149,385 | $10.3M | 0.57% |
| 40 | Marinus Pharmaceuticals Inc | 56854Q200 | 1,000,000 | $9.0M | 0.50% |
| 41 | PepGen Inc | PEPG | 503,624 | $7.4M | 0.41% |
| 42 | Cabaletta Bio Inc | CABA | 429,746 | $7.3M | 0.41% |
| 43 | Establishment Labs Hldgs Inc | ESTA | 141,162 | $7.2M | 0.40% |
| 44 | Achieve Life Sciences Inc | ACHV | 1,518,230 | $6.9M | 0.38% |
| 45 | Marinus Pharmaceuticals Inc | 56854Q200 | 750,000 | $6.8M | 0.38% |
| 46 | Soleno Therapeutics Inc | SLNO | 150,775 | $6.5M | 0.36% |
| 47 | 4D Molecular Therapeutics Inc | FDMT | 198,186 | $6.3M | 0.35% |
| 48 | Nextcure Inc | NXTC | 2,671,856 | $6.0M | 0.33% |
| 49 | Avantor Inc | AVTR | 232,446 | $5.9M | 0.33% |
| 50 | Madrigal Pharmaceuticals Inc | MDGL | 19,029 | $5.1M | 0.28% |
| 51 | Bolt Biotherapeutics Inc | BOLT | 2,754,437 | $3.9M | 0.21% |
| 52 | Masimo Corp | MASI | 20,000 | $2.9M | 0.16% |
| 53 | Teleflex Incorporated | TFX | 12,142 | $2.7M | 0.15% |
| 54 | Insmed Inc | INSM | 100,000 | $2.7M | 0.15% |
| 55 | Fusion Pharmaceuticals Inc | 36118A100 | 117,099 | $2.5M | 0.14% |
| 56 | Cooper Cos Inc | 216648501 | 21,236 | $2.2M | 0.12% |
| 57 | Inspire Med Sys Inc | 457730109 | 8,099 | $1.7M | 0.10% |
| 58 | LivaNova PLC | LIVN | 20,456 | $1.1M | 0.06% |
| 59 | Marinus Pharmaceuticals Inc | 56854Q200 | 104,700 | $946,488 | 0.05% |
| 60 | Nucana PLC | NCNA | 3,400,739 | $884,192 | 0.05% |
| 61 | Amylyx Pharmaceuticals Inc | AMLX | 306,729 | $871,110 | 0.05% |
| 62 | Baxter Intl Inc | 071813109 | 20,000 | $854,800 | 0.05% |
| 63 | Fusion Pharmaceuticals Inc | 36118A100 | 40,073 | $854,356 | 0.05% |
| 64 | Immatics NV | IMTX | 316,349 | $853,059 | 0.05% |
| 65 | Amylyx Pharmaceuticals Inc | AMLX | 300,000 | $852,000 | 0.05% |
| 66 | PDS Biotechnology Corp | PDSB | 142,635 | $564,835 | 0.03% |
| 67 | Ikena Oncology Inc | 45175G108 | 382,616 | $543,315 | 0.03% |
| 68 | Perspective Therapeutics Inc | CATX | 430,105 | $511,825 | 0.03% |
| 69 | Inari Med Inc | 45332Y109 | 10,216 | $490,164 | 0.03% |
| 70 | Disc Medicine Inc | IRON | 6,173 | $384,331 | 0.02% |
| 71 | Structure Therapeutics Inc | GPCR | 8,733 | $374,296 | 0.02% |
| 72 | Nucana PLC | NCNA | 1,307,875 | $340,048 | 0.02% |
| 73 | Kyverna Therapeutics Inc | KYTX | 10,000 | $248,400 | 0.01% |
| 74 | Mirum Pharmaceuticals Inc | MIRM | 3,012 | $75,661 | 0.00% |